Background. Myocardial injury after non-cardiac surgery (MINS), a complication with unclear pathogenesis, occurs within the first 30 days after surgery and worsens prognosis. Hypercoagulability induced by surgery might contribute to plaque rupture, with subsequent thrombosis and myocardial injury. This study assessed haemostatic markers before surgery and evaluated their association with MINS. Methods. This is a substudy of VISION, a prospective cohort study of perioperative cardiovascular events. Of 475 consecutive vascular surgery patients, 47 (9.9%) developed MINS, defined as postoperative high-sensitivity troponin !50 ng litre
Every year, >200 million adults undergo major non-cardiac surgery and >1 million people worldwide die within 30 days after surgery, mostly as a result of cardiovascular complications. 1 2 The most common cardiovascular complication is perioperative myocardial infarction (PMI). Moreover, several large studies have shown that postoperative cardiac troponin elevation adjudicated as attributable to myocardial ischaemia, irrespective of the PMI diagnosis, influences short-and long-term all-cause mortality. 3 4 Therefore, a new term, myocardial injury after non-cardiac surgery (MINS), was proposed in 2014 to cover a broader spectrum of perioperative myocardial injury than that defined by the universal definition of myocardial infarction. Myocardial injury after non-cardiac surgery is defined as the myocardial injury attributable to ischaemia that occurs within the first 30 days after non-cardiac surgery, which has a prognostic importance. 3 4 The diagnostic criterion for MINS is a troponin elevation within 30 days after non-cardiac surgery that is believed to be attributable to myocardial ischaemia. Ischaemic symptoms, ECG changes, or imaging evidence of a myocardial infarction are not required to establish the diagnosis. 5 Surgery and anaesthesia are associated with sympathetic nervous system activation, inflammation, hypercoagulability, bleeding, and hypothermia, all of which can trigger cardiac complications. 6 7 The pathological mechanism of MINS is not fully understood. 8 Two main mechanisms have been postulated, namely plaque rupture with subsequent acute thrombosis (type 1) and oxygen supply-demand mismatch (type 2). 9 10 Two retrospective autopsy studies in fatal PMI showed that nearly 50% of patients had a plaque disruption. 10 11 Moreover, Gualandro and colleagues 12 documented changes similar to type 1 myocardial infarction in almost 50% of PMI subjects in coronary angiography. Vascular patients undergoing non-cardiac surgery are among those at highest risk of developing MINS. 13 We hypothesized that vascular patients who develop MINS have altered coagulation status and more pronounced inflammation before surgery, which predisposes them to develop cardiac ischaemia when exposed to surgery and anaesthesia. Therefore, the aims of our study were to measure preoperative blood concentrations of coagulation activation and fibrinolysis markers and to evaluate their association with the development of MINS.
Methods

Subjects
This was a nested case-control study conducted between October 2010 and November 2013 as a part of the international Vascular events In non-cardiac Surgery patIents cohort evaluatioN (VISION) Study (NCT00512109). The main objective of VISION was to determine the incidence of major perioperative vascular events after non-cardiac surgery. Inclusion criteria were as follows: patients !45 yr of age who received general or regional anaesthesia for non-cardiac surgery and stayed at least overnight in the hospital after the procedure. In this substudy, we recruited 475 consecutive patients who underwent elective surgery for peripheral artery disease or an abdominal aortic aneurysm in the Vascular Surgery Department, St John Grande Hospital, Krakow, Poland. We excluded patients who had vascular surgery for carotid artery disease or for an acute bypass graft thrombosis. We also excluded patients who had cancer, estimated glomerular filtration rate <30 ml min
À1
, deep vein thrombosis during 3 months before surgery, or acute infection. Myocardial injury after non-cardiac surgery events was adjudicated by the VISION Adjudication Committee. The study was approved by the local ethics committee. The protocol complied with the Declaration of Helsinki. All participants provided written informed consent before being enrolled.
Research personnel interviewed patients and reviewed their medical records to obtain information on potential preoperative predictors of major perioperative complications and factors that influence the coagulation system before surgery (age, sex, history of hypertension, current or previous smoking status, diabetes mellitus, overweight, atrial fibrillation, coronary artery disease (CAD), and stroke or transient ischaemic attack; preoperative use of anticoagulants, antiplatelet agents, and statins; and platelet count). In all patients, high-sensitivity troponin T (hsTnT; Elecsys 2010 analyzer; Roche, Meylan, France) was measured before surgery, 6-12 h after surgery, and on the first, second, and third day after surgery. The 99th percentile threshold for hsTnT in the healthy population is 14 ng litre À1 (robust coefficient of variation >85%). 14 Additionally, blood samples (serum and plasma) were obtained before surgery and stored immediately after centrifugation at À80 C. Study personnel followed patients throughout their hospitalization and 30 days and 1 yr after surgery to determine outcome events. Subjects in this study were patients who had a postoperative hsTnT concentration !50 ng litre À1 and !20% absolute increase from the preoperative concentration. This threshold was chosen because it corresponds to the 30 ng litre À1 cut-off point in the fourth-generation assay (the concentration used to define MINS in non-cardiac surgery settings). [15] [16] [17] The control group consisted of non-MINS patients matched by age, sex, indication for surgery, cardiovascular risk factors, and heparin use before surgery.
Biomarkers
The following blood biomarkers were measured in platelet-poor plasma from all patients.
Coagulation activation and fibrinolysis
The markers were as follows: antithrombin (chromogenic method; Innovance Antithrombin; Siemens, Marburg, Germany), activity of factor VIII (one-stage clotting assay; Siemens), concentration of von Willebrand factor (vWF:Ag; ELISA method; Zymutest vWF; Hyphen BioMed, Andresy, Editor's key points
• Myocardial injury after non-cardiac surgery (MINS), as defined by troponin elevation within 30 days of surgery, correlates with poorer prognosis.
• In a retrospective subanalysis of vascular surgery patients from the VISION study, patients with MINS had preoperative elevation of biomarkers for hypercoagulability and inflammation.
• Preoperative hypercoagulability and inflammation predict MINS, which provides a potential target for preoperative risk reduction.
Technoclone, Vienna, Austria), and tissue plasminogen activator (ELISA method; Zymutest t-PA Antigen, Hyphen BioMed).
Inflammatory markers
The markers were as follows: C-reactive protein (CRP; ELISA method; Human C-Reactive Protein ELISA; R&D, UK) and soluble CD40 ligand (ELISA method; CD40 Quantikine ELISA Kit; R7D, UK).
Statistical analysis
The study groups were matched in a 1:2 ratio (cases vs controls) according to sex, age, reason for surgery, and medical history (hypertension, current or previous smoking, diabetes mellitus, overweight, atrial fibrillation, CAD, stroke or transient ischaemic attack, perioperative drug administration, and platelet count).
Categorical variables are presented as counts (percentages), whereas continuous variables are reported as medians (25-75 quartile range) unless otherwise specified. Categorical variables were compared between MINS and non-MINS groups by Fisher's exact test, and continuous variables were compared by using Student's unpaired t-test or the Mann-Whitney U-test as appropriate. Data for D-dimer and plasmin-antiplasmin complexes were natural logarithmically transformed to approximate a normal distribution (Kolmogorov-Smirnov test). Statistical analyses were performed with Statistica 12 software (StatStoft, Tulsa, OK, USA). A two-sided P-value <0.05 was considered statistically significant. Graphs were created with the use of GraphPad Prism 7 software (GraphPad, San Diego, CA, USA).
Results
According to the study criteria, MINS was diagnosed in 47 patients (47/475; 9.9%), and 84 patients were selected as the control group (non-MINS). There were no significant differences between the MINS and non-MINS groups in terms of age, sex, indication for surgery, statin use, antiplatelet drug use, heparin use, or platelet count before surgery. Both groups were similar in terms of co-morbidities aside from history of stroke or transient ischaemic attack, which occurred more often in the MINS group. In the MINS group, diabetes mellitus and history of CAD were slightly more frequent and atrial fibrillation less frequent, but these differences did not reach statistical significance (P>0.05; Table 1 ).
The median hsTnT concentration before surgery was 12.0 (8.0-20.0) ng litre À1 . Detailed patient characteristics are shown in Table 1 . The MINS group had a higher 1 yr mortality compared with the non-MINS group (21 vs 8.3%, P¼0.03). The most common causes of death in the MINS group were vascular (80%), whereas non-vascular causes accounted for the remaining 20% of deaths. In the non-MINS group, 14% of deaths were vascular, 29% were non-vascular, and causes of 57% of deaths were not determined. Preoperative concentrations of factor VIII, vWF:CoR, vWF:Ag, fibrinogen, D-dimer, and PAP, but not antithrombin or tissue plasminogen activator, were significantly higher in the MINS group. Patients in the MINS group had higher concentrations of CRP, with no differences in CD40L. Detailed results of the biomarkers studied can be found in Table 2 and Fig. 1 .
Discussion
Vascular patients with MINS had higher preoperative blood concentrations of hypercoagulability blood markers than those who did not develop MINS. Arterial complications are common in patients undergoing vascular surgery for peripheral artery disease or an abdominal aortic aneurysm, and it is not surprising that 9.9% of our cohort developed MINS. The MINS patients had a 21% mortality rate at 1 yr compared with 8.3% in those who did not develop MINS.
Although the role of perioperative changes in the coagulation system is unclear, hypercoagulation and diminished function of the fibrinolytic system can contribute to cardiovascular complications such as myocardial ischaemia or ischaemic stroke in a non-surgical setting. [18] [19] [20] [21] Von Willebrand factor exists in the blood as a complex with coagulation factor VIII. It is produced mostly by the endothelium in response to injury or inflammation and promotes the formation of thrombus. 22 23 The vWF:Ag reflects the amount of the factor in the plasma, whereas vWF:CoR measures its activity. Elevated vWF has been shown to be a risk factor for poor clinical outcomes, ischaemic events, or both, in patients with coronary artery disease, myocardial infarction, ischaemic stroke, and congestive heart failure. [24] [25] [26] We found that plasma concentrations of factor VIII and both vWF:Ag and vWF:CoR were higher in the MINS group compared with the non-MINS group. Moreover, vWF activity was strongly correlated with factor VIII activity. These results suggest that the haemostatic system in patients who will suffer MINS is already activated before surgery. Such activation could, at least in part, relate to the enhanced inflammation reflected in the present study by the concomitant elevation of CRP concentrations in the MINS group, even after exclusion of patients with overt infection. C-Reactive protein is a marker of systemic inflammation and is correlated with an increased risk of cardiovascular diseases and mortality in patients with an established cardiovascular risk or documented atherosclerosis. [27] [28] [29] There is a growing evidence of extensive cross-talk between coagulation and inflammation, where not only inflammation leads to activation of coagulation, but also coagulation influences inflammatory activity. 30 The relationship between CRP and fibrinogen and their role in prediction of cardiovascular events is already known and was confirmed in patients without a history of cardiovascular disease in large studies. 31 32 In the vascular surgical population, where atherosclerosis is pronounced, this relationship can contribute to thrombotic complications. The fibrinolytic pathway involves several steps, leading to final degradation of fibrin by plasmin with formation of fragment D-dimer molecules (D-dimer). Plasmin generation can be measured in plasma by assessing plasmin complexes formed with its main inhibitor, antiplasmin (PAP complexes). Therefore, both D-dimer and PAP are markers of ongoing fibrinolytic system activity. The association between high concentrations of plasma D-dimer and subsequent cardiovascular events has been documented in the general population and in patients with unstable angina. [33] [34] [35] An elevated concentration of D-dimer has also been shown to be a risk factor for coronary heart disease independently from other classical risk factors and, together with elevated PAP, was reported to predict myocardial infarction in men and women >65 yr of age. 34 36 37 Results of the present study indicate that both markers are also associated with a higher risk of MINS in patients undergoing vascular surgery. Both coagulation and fibrinolytic activities are altered by surgical procedures depending on the type of surgery. 38 Significant activation of coagulation and fibrinolysis occurs after major vascular surgery and is associated with an increased risk of perioperative myocardial cell damage. 39 Some studies suggest that in the very early postoperative period there may be transient inhibition of fibrinolysis. 40 We hypothesize that in patients with increased activation of coagulation and increased fibrinolysis before surgery, the anaesthesia and surgery shift the balance towards a prothrombotic state, contributing to development of MINS.
Our study has several limitations, including the relatively low number of MINS patients, which limited our ability to adjust for baseline differences between cases and controls. Even though differences were not statistically significant, we observed a higher proportion of patients with diabetes mellitus, atrial fibrillation, and CAD in the MINS group, which could influence coagulation and inflammatory status before surgery and, at least partly, explain the differences in measured biomarkers. Only selected groups of coagulation, fibrinolysis, and inflammatory factors were measured, and we were not able to explore the possible effects of perioperative haemostatic changes on the development of MINS. Finally, although equally distributed between the groups, anticoagulant use could affect some of the biomarker measurements.
This study draws attention to the possible role of preoperative hypercoagulability in the development of MINS in vascular surgery patients. Our results demonstrate that increased activation of the haemostatic and fibrinolytic systems is associated with a higher risk of MINS. This suggests that the pathogenesis of MINS is more similar to that of type 1 myocardial infarction than type 2 myocardial infarction. Assessment of additional markers in a larger cohort of patients with evaluation of perioperative coagulation changes would further improve our understanding of the role of these processes in development of MINS. Such knowledge could not only help to identify possible markers of hypercoagulability that are associated with MINS but also contribute to discovery of potential targets for treatment.
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